VISA-G
An index of the severity of greater trochanteric pain syndrome
What is the VISA-G?
The VISA-G (Victorian Institute of Sport Assessment for Gluteal Tendinopathy) is a validated patient-reported outcome measure designed to assess the severity of disability in individuals with Greater Trochanteric Pain Syndrome. It consists of eight items that evaluate pain levels and functional limitations related to the hip. The total score ranges from 0 to 100, with higher scores indicating better function and less pain. This instrument is widely used in both clinical and research settings to monitor patient progress, evaluate treatment effectiveness, and provide standardised measurement of gluteal tendinopathy severity.
Scoring System
The VISA-G comprises eight questions, each scored individually on specific scales. The total score is calculated by summing all individual item scores, resulting in a range from 0 to 100. Higher scores reflect better function and less disability. The questionnaire includes questions about pain during daily activities, functional limitations, and the ability to participate in physical activities. Each question uses a visual analogue scale or multiple-choice format, with scores weighted to reflect the clinical importance of different aspects of the condition. The questionnaire has demonstrated good reliability (test-retest reliability) and validity in assessing the severity of gluteal tendinopathy across diverse patient populations.
General Information
Clinical Information
Instructions
In this questionnaire, the term "pain" refers specifically to your hip pain. Please answer each question based on your experiences with hip pain during your typical activities and any limitations you face.
Form Preview
See how the form looks and try the interactive version
VISA-G
An index of the severity of greater trochanteric pain syndrome
Instructions:
In this questionnaire, the term "pain" refers specifically to your hip pain. Please answer each question based on your experiences with hip pain during your typical activities and any limitations you face.
Main Assessment (Questions 1-6)
0/10 = worst pain | 10/10 = no pain
Select the option that best describes your situation
Select the option that best describes your situation
Select the option that best describes your situation
Select the option that best describes your situation
Select the option that best describes your situation
Activity Level (Questions 7-8)
Select the option that best describes your situation
8. Do you have pain undertaking weight bearing activities?
Type: visa-g-8
8. Please complete EITHER A, B or C in this question. If you have no pain while undertaking weight bearing activities please complete Q8a only. If you have pain while undertaking weight bearing activities but it does not stop you from completing the activity, please complete Q8b only. If you have pain that stops you from completing weight bearing activities, please complete Q8c only.
Patient Watch Form - 10/31/2025
Detailed Scoring Methodology
The VISA-G comprises eight questions, each scored individually on specific scales. The total score is calculated by summing all individual item scores, resulting in a range from 0 to 100. Higher scores reflect better function and less disability. The questionnaire includes questions about pain during daily activities, functional limitations, and the ability to participate in physical activities. Each question uses a visual analogue scale or multiple-choice format, with scores weighted to reflect the clinical importance of different aspects of the condition. The questionnaire has demonstrated good reliability (test-retest reliability) and validity in assessing the severity of gluteal tendinopathy across diverse patient populations.
Meaningful Change Threshold
A change of approximately 6.9 to 18.4 points is considered the smallest detectable change (SDC), indicating a meaningful improvement or deterioration in the patient's condition. The minimal clinically important difference (MCID) varies between studies, but changes of 10 points or more are generally considered clinically significant. Clinicians should interpret score changes in the context of individual patient presentations and treatment goals.
About the Developers
The VISA-G was developed by a team of researchers led by Dr. Alison Grimaldi and colleagues at the Victorian Institute of Sport Assessment. The development process involved extensive clinical expertise in gluteal tendinopathy, patient input, and rigorous psychometric testing to ensure the questionnaire accurately captures the impact of Greater Trochanteric Pain Syndrome on patients' lives. The original validation study was published in 2015, establishing the VISA-G as a reliable and valid condition-specific outcome measure.
Copyright Information
The VISA-G is freely available for clinical and research use without licensing fees. Users should cite the original development and validation study when using the questionnaire in research publications or clinical documentation. No permission is required for clinical or research applications.
Administration Instructions
In this questionnaire, the term "pain" refers specifically to your hip pain. Please answer each question based on your experiences with hip pain during your typical activities and any limitations you face.
Limitations & Considerations
Whilst the VISA-G is a validated and reliable tool, it may not capture all aspects of disability experienced by individuals with Greater Trochanteric Pain Syndrome. The questionnaire focuses primarily on pain and functional limitations but may not fully assess psychological factors, quality of life impacts, or comorbid conditions. It should be used in conjunction with other clinical assessments, physical examinations, and imaging studies when appropriate. The applicability to diverse populations and cultural contexts requires further study. Additionally, as a self-reported measure, it is subject to response bias and may be influenced by patient expectations or recall bias.
Ready to implement VISA-G?
Get started with our comprehensive digital platform for patient assessment and monitoring.